TokenPost·
Alnylam Reports Mutant Protein Reduction in Highest-Dose Trial Group
60% to 64%
mutant protein reduction
The highest-dose group had a 60% to 64% mean reduction in spinal-fluid mutant huntingtin three months after one dose, but the early study has not shown disease slowing.